Immunogen
Synthesized peptide derived from SARS-COV-2 Spike Protein
Specificity
This antibody detects endogenous levels of SARS-COV-2 Spike Protein
Source
Polyclonal, Rabbit,IgG
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.16% sodium azide.
Dilution rate
WB 1:1000-2000
Purification process (Immunogen)
The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
Background
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor.
Gene Name
SARS-COV-2 Spike Protein
Protein name
SARS-COV-2 Spike Protein
Abbreviation
SARS-COV-2 Spike
Human protein sequence Database
P0DTC2
Mouse protein sequence database
Rat protein sequence database
Contract Us
Follow Us
Location： 
Specification
成功添加到购物车